课题基金 / 基金详情

Molecular Recognition during pre-mRNA Splicing

Molecular Recognition during pre-mRNA Splicing
mRNA 前体剪接过程中的分子识别
批准号:
8205112
负责人:
CLARA KIELKOPF
金额:
$4.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2013-06-30

项目摘要

项目成果

CLARA KIELKOPF的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):pre- mrna的剪接为细胞分化和发育提供了转录物多样性的主要来源。已知这一过程需要一个由约100个蛋白质和5个小核rna组成的剪接机器(剪接体)。在前mrna剪接位点上剪接体组装的早期阶段是人类遗传疾病和癌症中经常出错的关键调控步骤。然而,在分子水平上,剪接体究竟如何从数千个竞争的前mrna序列中选择和切除正确的剪接位点仍然知之甚少。因此,本建议的总体目标是了解在剪接体激活的早期阶段指导3'剪接位点选择的连续三维相互作用。必不可少的剪接因子U2AF和SF1的复合体识别3'剪接位点附近的pre-mRNA序列,进而稳定核心剪接体的结合。通过U2AF的精氨酸-丝氨酸(RS)区域和U2AF相关的atp酶UAP56进行前mrna接触是完成这一任务所必需的。本提案的具体目的是解决以下关于pre-mRNA剪接关键早期阶段的核心问题:(1)U2AF通过什么方式识别不同的剪接位点?(2) SF1通过什么方式增强U2AF对剪接位点的识别?(3) U2AF以何种方式招募UAP56,而UAP56在剪接位点对U2AF的作用又是什么?(4) RS区通过什么方式促进剪接体snrna与前体mrna的结合?我们已经通过(i)确定U2AF结合剪接位点的三维结构,(ii)评估SF1结构域对U2AF结合的热力学和结构贡献,以及(iii)表征RS结构域的RNA相互作用,在这些目标上取得了重大进展。这些研究将极大地促进我们对基因表达这一基本步骤的理解。公共卫生相关性:mrna前体剪接错误导致主要的人类疾病,包括癌症、白血病、肌强直性营养不良、神经和代谢紊乱。对正常剪接位点识别的调查将通过拟议的工作获得,将作为理解的基础,并在长期开发治疗,有害的人类疾病剪接变异。
英文摘要
DESCRIPTION (provided by applicant): Splicing of pre-mRNAs provides a major source of transcript diversity for cell differentiation and development. It is known that this process requires a splicing machine (spliceosome) composed of ~100 proteins and 5 small nuclear (sn)RNAs. The early stages of spliceosome assembly on pre-mRNA splice sites are key regulated steps that often go awry in human genetic diseases and cancers. Yet, exactly how the spliceosome selects and excises the correct splice sites from amidst thousands of competing pre-mRNA sequences remains poorly understood at the molecular level. Hence, the overall goal of this proposal is to understand the sequential three- dimensional interactions that guide 3' splice site selection in the early stages of spliceosome activation. A complex of the essential splicing factors U2AF and SF1 recognizes pre-mRNA sequences adjacent the 3' splice site, and in turn stabilizes association of the core spliceosome. Pre-mRNA contacts by an arginine-serine (RS) region of U2AF, and the U2AF-associated ATPase UAP56, are required to accomplish this task. Specific aims of this proposal address the following central questions concerning the critical early stages of pre-mRNA splicing: (1) By what means does U2AF recognize diverse splice sites? (2) By what means does SF1 enhance splice site recognition by U2AF? (3) By what means does U2AF recruit UAP56, and in turn, what is the action of UAP56 on U2AF at the splice site? (4) By what means does an RS region promote association of spliceosomal snRNAs with the pre-mRNA? We have already made significant advances towards these aims by (i) determining three-dimensional structures of U2AF bound to splice sites, (ii) evaluating thermodynamic and structural contributions of SF1 domains to U2AF binding, and (iii) characterizing RNA interactions by RS domains. These studies will significantly advance our understanding of this fundamental step of gene expression. PUBLIC HEALTH RELEVANCE: Errors in pre-mRNA splicing contribute to major human diseases, including cancers, leukemias, myotonic dystrophies, neurological and metabolic disorders. The investigation of normal splice site recognition to be gained by the proposed work would serve as a basis for understanding, and in the long term developing treatments against, harmful splice variants of human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Control of Human Co-factors for Retroviral Gene Expression
  • 批准号:
    9008671
  • 项目类别:
  • 资助金额:
    $29.55万
  • 财政年份:
    2016
  • 负责人:
    CLARA KIELKOPF
  • 依托单位:
Structural Control of Human Co-factors for Retroviral Gene Expression
  • 批准号:
    9341781
  • 项目类别:
  • 资助金额:
    $8.45万
  • 财政年份:
    2016
  • 负责人:
    CLARA KIELKOPF
  • 依托单位:
MOLECULAR RECOGNITION DURING PRE-MRNA SPLICING
  • 批准号:
    8362295
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2011
  • 负责人:
    CLARA KIELKOPF
  • 依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
  • 批准号:
    8363522
  • 项目类别:
  • 资助金额:
    $0.57万
  • 财政年份:
    2011
  • 负责人:
    CLARA KIELKOPF
  • 依托单位:
海外基金